Name: IO Biotech, Inc. (IOBT) Balance Sheet
Creator: FinSpry

IO Biotech Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for IO Biotech, Inc. (IOBT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	60.03	143.19	142.59	211.53	3.41
Cash & Short-Term Investments	60.03	143.19	142.59	211.53	3.41
Accounts Receivable	1.13	1.13	1.53	2.09	1.50
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.12	1.35	2.28	3.20	0.00
Total Current Assets	64.95	147.26	148.22	221.74	5.64
Non-Current Assets
Property, Plant & Equipment (Net)	2.36	3.11	3.23	0.16	0.00
Long-Term Investments	0.27	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.39	0.36	0.35	0.40	0.02
Total Non-Current Assets	2.75	3.46	3.59	0.55	0.00
Total Assets	67.70	150.72	151.81	222.29	5.65
Current Liabilities
Accounts Payable	4.66	3.88	4.00	3.93	0.52
Short-Term Debt	0.72	0.00	0.00	0.00	0.00
Accrued Liabilities	13.61	10.62	2.34	5.92	2.27
Other Current Liabilities	0.50	0.56	1.95	0.46	0.26
Total Current Liabilities	19.49	15.72	10.68	10.31	3.05
Non-Current Liabilities
Long-Term Debt	1.20	1.84	2.28	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.06	0.00
Total Non-Current Liabilities	1.20	1.84	2.28	0.06	0.00
Total Liabilities	20.68	17.56	12.95	10.36	3.05
Stockholders' Equity
Common Stock	0.07	0.07	0.03	0.03	0.03
Retained Earnings	-359.31	-263.82	-177.74	-106.28	-38.40
Accumulated Other Comprehensive Income	-6.85	-9.67	-10.14	-1.49	1.96
Additional Paid-in Capital	413.11	406.59	326.71	319.67	0.00
Shares Outstanding	65.88	65.88	28.82	28.82	0.00
Total Stockholders' Equity	47.02	133.16	138.85	211.92	2.60
Total Liabilities & Equity	67.70	150.72	151.81	222.29	0.00